MD TP10c: In vivo validation of T cell inhibitory compounds

Based on the results of MD TP10, where 15 T cell inhibitory compounds were identified by library screening, we here evaluate the prophylactic / therapeutic effect of these compounds in vivo. The compounds are tested in models of psoriasis, epidermolysis bullosa acquisita and experimental autoimmune encephalitis.